Skeletal, Metabolic and Neurobehavioral Core (SMNC)
Icahn School Of Medicine At Mount Sinai, New York NY
Investigators
Linked publications & trials
Abstract
PROJECT SUMMARY Our extended Skeletal, Metabolic and Neurobehavioral Core (Core A, SMNC) is a resourceâ and expertiseâbased core that supports all Projects across the primary and collaborating sites. It represents a transdisciplinary expansion of our current Core Aâand now comprises a battery of six neurobehavioral tests and two stereotactic brain injection platforms, in addition to stateâofâtheâart facilities for skeletal and metabolic phenotyping. For the rodentâbased Projects 1 through 3, we require the estimation of body fat, bone marrow adipose tissue, energy expenditure, bone structure and function, neurobehavioral testing and/or stereotactic injections, while all projects, including Project 4, need serum hormone assays. Thus, our expanded Core A will provide dualâenergy Xâray absorptiometry (OsteoSys), quantitative nuclear magnetic resonance (qNMR, EchoMRI-100), metabolic cages (Promethion), ELISA platforms, and a full complement of histology, immunohistochemistry and bone histomorphometry. At Maine Medical Center Research Institute (MMCRI), Core A will provide osmium microâcomputed tomography (µCT, VivaCT-40 for bone marrow adipose tissue, and when required, qNMR (Bruker-7T) for body fat. Core A will also serve as a sample storage and distribution center. For bone µCT and 4âpoint bending tests, Core A will send bone samples to Dr. Jay Cao (U.S. Department of Agriculture, Grand Forks, North Dakota) and Dr. Mary Bouxsein (Beth Israel Deaconess Medical Center, Harvard Medical School), respectively. For select studies, geneticallyâengineered mice will be relocated to Dr. Edward Guoâs laboratory at Columbia Universityâs Department of Biomedical Engineering for the measurement of fat depots by µCT (VivaCT-40). Finally, and importantly, Core A will continue to maintain our MediaLab Document Control System as a repository for data reâanalysis, crossâ institutional validation, and overall provenance. All U19 investigators will have unfettered access to all data files, supporting our continued attempts to ensure rigor and transparency.
View original record on NIH RePORTER →